International Society for the Study of Vascular Anomalies
Newsletter Vol 1 - No 1 | April 2017
Since ISSVA 2016 in Buenos Aires, Argentina, we have been closely working with Executive Director, Inc (EDI), to professionalize ISSVA. The engagement of EDI has allowed us to increase our efficiency in important administrative matters. EDI assists us in all of the everyday duties of our Society, including keeping track of our membership, helping the secretary and the treasurer, and rejuvenating and keeping up-to-date our website. EDI will also help the local hosts in organizing the future ISSVA meetings. Our referent at EDI is Justin Dodge.
As the daily practices of ISSVA are now better organized, we can expand the activities that ISSVA would like to develop for our membership and the patients we serve. To this end, we have already expanded the size of the Board of Directors in Buenos Aires to have a larger representation of our multidisciplinary membership.
We are pleased that Tony Penington and Michel Wassef accepted to serve ISSVA as Members-At-Large and I’d also like to welcome the other new ISSVA Board members, Josée Dubois as the Vice President and Francine Blei, who is the Chair of the Scientific Committee.
Another objective was to develop a Newsletter to keep our membership informed on ISSVA activities and to connect all ISSVA members. The Newsletter is currently planned to appear twice a year, and to focus on news, ISSVA projects and literature reviews.
I would like to thank Josée Dubois, who accepted the charge of editor as well as Ilona Frieden, Gresham Richter, Francine Blei and all the members of the scientific committee, for setting up this first issue of the newsletter. I hope you will find every section of great interest.
We have many other projects in mind, such as the development of international registries, and creating guidelines for outcome measures and management etc. These are also within the objectives of the recently established European Reference Network VASCERN, which comprises recognized centers for vascular anomalies; a tight collaboration would likely be most beneficial.
Our Society has grown from the small friendly club of the 1980s to an international multi-disciplinary society. This is thanks to the work and engagement of all previous ISSVA presidents, board members, the increasing number of dedicated members, and the world-wide increase of interest in vascular anomalies. As Steven Fishman, our past president recalled: “We must strive to cherish and maintain the strengths of our past traditions while embracing the future”.
One of the unique characteristics of ISSVA is its multidisciplinarity, which is the foundation of quality management of vascular anomaly patients. We should continue this work and tighten our international collaborations, and distribute our knowledge to those parts of the world where vascular anomaly patients still wander as nomads.
One of the steps to help distribute information and help patients find us, is to publish the location of the members and their centers on the ISSVA web-site.
Please go to the web-site Member Login, and look under > User Profile > Public Directory, and update your profile!
Our society is developing rapidly and the future is bright. The preparation of the ISSVA Amsterdam meeting 2018 is well under way.
I hope to see you all there in ever increasing numbers!
Laurence M Boon
ISSVA President
Preparations for ISSVA 2018 are in progress! We have a great location on the river a short distance from the centre of Amsterdam. Plus, our many hotels are all within walking distance.
In addition to the Workshop and the primer course, we will schedule half a day for advanced courses. The following topics are being considered: Genetics, Pathology, Surgery and Interventional Radiology. These courses are scheduled to take place the day before the Workshop begins.
December 2017: Online registration opens
05 December 2017: Abstracts open
15 January 2018: Abstracts close
16 March 2018: Early registration
01 May 2018: Regular registration
Editor: Francine Blei, MD
Contributors:
â— Karthik Balakrishnan, MD*/ Jonathan Perkins, DO – Otolaryngology
â— Michael Dellinger, PhD*/ Francine Blei, MD – Lymphatic Biology, Pathophysiology
â— Anne Dompmartin, MD – Dermatology
â— Israel Fernandez-Pineda, MD*/ Juan Carlos Lopez Guttierez, MD, PhD – Surgery
â— Dov Goldenberg, MD – Plastic Surgery
â— Ionela Iocobas, MD*/ Denise Adams, MD – Pediatric Hematology Oncology
â— Anna Lillis, MD*/ Gulraiz Chaudry, MD – Interventional Radiology
â— Zerina Lokmic Tomkins, PhD*/ Tony Penington, MD – Basic Science
â— Kristina W. Rosbe, MD – Otolaryngology
Junior ISSVA Member*/Scientific Committee Member
Our contributors have scanned the literature by discipline and provided a short synopsis. Click on the topics below to access their review.
â— GENETICS & BASIC SCIENCE
â— LYMPHATIC DISORDERS
â— VASCULAR MALFORMATIONS
â— HEMANGIOMAS – PATHOGENESIS AND TREATMENT
â— VASCULAR MALIGNANCIES
Presenters are in bold
Overexpression of VEGF-C in bone induces a Gorham-Stout disease-like phenotype.
Asitha Silva, Jian Feng, Paul Dechow, Kari Alitalo, Michael Dellinger. UT Southwestern Medical Center, Texas A&M Baylor College of Dentistry, University of Helsinki.
Development of A Set of Core Outcome Measures for Vascular Malformations (OVAMA Project): An International E-Delphi Consensus Study.
Sophie E.R. Horbach, Chantal M.A.M. van der Horst, Dirk T. Ubbink, OVAMA consensus group, Phyllis I. Spuls. Plastic and reconstructive surgery, Academic Medical Center - Amsterdam (AMC) , Surgery and Epidemiology (AMC), OVAMA project, Dermatology (AMC)
When Do Hemangiomas Need Treatment? A Predictive Scoring System to Screen for Early Referral.
Sarah Chamlin, Jin-Shei Lai, Jennifer Beaumont, Eulalia Baselga, Elizabeth Rancour and Anita Haggstrom.
SAVE THE DATE! 23nd International Workshop of the International Society for the Study of Vascular Anomalies 13-15 May 2020 |
Special thanks:
Nathalie Samson for her assistance with the design and development of the newsletter!